BioRestorative Therapies, Inc. Share Price
Stocks
BRTX
US0906557055
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
02:00:00 31/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.400 USD | -11.37% |
|
-13.56% | -94.04% |
| 10/10 | BioRestorative Therapies, Inc. Announces Board and Committee Changes | CI |
| 06/10 | Maxim Downgrades BioRestorative Therapies to Hold From Buy | MT |
| Market Cap | 17.84L 15.98L 14.7L 13.32L 24.89L 17Cr 25.36L 1.75Cr 70.35L 8.91Cr 66.95L 65.52L 28Cr | P/E 2026 * |
-0.11x | P/E 2027 * | -0.13x |
|---|---|---|---|---|---|
| Enterprise Value | 17.84L 15.98L 14.7L 13.32L 24.89L 17Cr 25.36L 1.75Cr 70.35L 8.91Cr 66.95L 65.52L 28Cr | EV / Sales 2026 * |
5.75x | EV / Sales 2027 * | 1.19x |
| Free-Float |
93.78% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BRTX | Delayed | |
Tradegate
| 9OF0 | Real-time | |
|
CBOE
| BRTX | Real-time | |
|
Deutsche Boerse AG
| 9OF0 | Delayed |
Last Transcript: BioRestorative Therapies, Inc.
| 1 day | -11.37% | ||
| 1 week | -13.56% | ||
| 1 month | -39.90% | ||
| 3 months | -65.80% | ||
| 6 months | -68.90% | ||
| Current year | -94.04% |
| 1 week | 1.36 |  | 1.65 |
| 1 month | 1.28 | | 2.43 |
| Current year | 1.28 | | 25.6 |
| 1 year | 1.28 | | 31 |
| 3 years | 1.28 | | 73.4 |
| 5 years | 1.28 | | 298.8 |
| 10 years | 1.28 | | 4,00,800 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mika Grasso
CEO | Chief Executive Officer | 28 | 27/08/2026 |
Anna Skowron
DFI | Director of Finance/CFO | 38 | 27/08/2026 |
Rory Rumore
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Mika Grasso
BRD | Director/Board Member | 28 | 12/06/2026 |
Jay Dhaliwal
BRD | Director/Board Member | 37 | 12/06/2026 |
Esha Randhawa
BRD | Director/Board Member | - | 13/07/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 06/10/25 | Free | Chief Technology Officer | 23,438 | 0.2938% | ||
| 06/10/25 | Free | Chief Executive Officer | 27,344 | 0.3427% | ||
| 14/02/25 | Other | Chief Technology Officer | 7,68,979 | 11.1125% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -11.37% | -13.56% | -95.45% | -96.46% | 17.84L | |
| -0.62% | -1.87% | +42.87% | +64.15% | 6.38TCr | |
| +0.35% | +3.20% | +14.40% | +81.76% | 5.64TCr | |
| +0.53% | +1.96% | +16.24% | +103.35% | 5.46TCr | |
| -2.81% | -4.31% | +23.50% | +47.83% | 4.41TCr | |
| -0.33% | -1.93% | +19.28% | +98.80% | 4.21TCr | |
| +0.55% | +2.31% | +225.14% | +866.21% | 4.1TCr | |
| +3.27% | +47.96% | +112.84% | +96.58% | 3.49TCr | |
| +1.22% | -1.44% | +14.57% | +46.95% | 3.28TCr | |
| +0.89% | +20.55% | -40.62% | +349.24% | 2.47TCr | |
| Average | -0.83% | +5.43% | +33.28% | +165.84% | 3.94TCr | |
| Weighted average by Cap. | +0.18% | +5.44% | +47.99% | +176.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3L 3L 3L 2L 4L 2.94Cr 4L 30.45L 12.23L 1.55Cr 11.63L 11.39L 4.88Cr | 15L 13.43L 12.36L 11.2L 20.93L 14Cr 21.32L 1.47Cr 59.16L 7.49Cr 56.29L 55.1L 24Cr |
| Net income | -1.66Cr -1.49Cr -1.37Cr -1.24Cr -2.32Cr -157.96Cr -2.36Cr -16Cr -6.56Cr -83Cr -6.24Cr -6.11Cr -262.04Cr | -1.63Cr -1.46Cr -1.34Cr -1.22Cr -2.28Cr -154.95Cr -2.32Cr -16Cr -6.44Cr -82Cr -6.12Cr -5.99Cr -257.05Cr |
| Net Debt | - | - |
Employees
14
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | $1.400 | -11.37% | 28,799 |
| 29/26/29 | $1.580 | +13.67% | 2,33,644 |
| 28/26/28 | $1.390 | +2.21% | 17,910 |
| 27/26/27 | $1.360 | -13.92% | 8,690 |
| 26/26/26 | $1.580 | -2.47% | 35,010 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.400USD
Average target price
300.00USD
Spread / Average Target
+21,323.98%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BRTX Stock
Select your edition
All financial news and data tailored to specific country editions
